1 |
<p><b>Our Profile</b></p> |
2 |
<p>The Fine Chemicals business has traditionally been oriented towards exports, |
3 |
approximately 90% of its production is exported. 10% is sold intra-group on |
4 |
an arm's length basis. </p> |
5 |
<table width="500" border="0" cellspacing="0" cellpadding="0"> |
6 |
<tr> |
7 |
<td width="220" align="right" height="145"><img src="fc/graph_1.gif" width="200" height="129" name="graph" alt="pie graph"></td> |
8 |
<td width="280" align="center"> |
9 |
<table width="220" border="0" cellspacing="0" cellpadding="0"> |
10 |
<tr> |
11 |
<td width="50"><img src="fc/graph_13.gif" width="45" height="24"></td> |
12 |
<td width="170"><font color="#CC6633"><b>Croatia</b></font></td> |
13 |
</tr> |
14 |
<tr> |
15 |
<td width="50"><img src="fc/graph_12.gif" width="45" height="24"></td> |
16 |
<td width="170"><font color="#CC6633"><b>Captive</b></font></td> |
17 |
</tr> |
18 |
<tr> |
19 |
<td width="50"><img src="fc/graph_11.gif" width="45" height="24"></td> |
20 |
<td width="170"><font color="#CC6633"><b>Export </b></font></td> |
21 |
</tr> |
22 |
</table> |
23 |
</td> |
24 |
</tr> |
25 |
</table> |
26 |
<p><b>Exports by region:</b> <br> |
27 |
64% of Fine Chemicals production is exported to the United States, 35% to Western |
28 |
Europe and 1% to others.</p> |
29 |
<table width="450" border="0" cellspacing="0" cellpadding="0"> |
30 |
<tr> |
31 |
<td width="30"> </td> |
32 |
<td> |
33 |
<table width="220" border="0" cellspacing="0" cellpadding="0"> |
34 |
<tr> |
35 |
<td width="175"><img src="fc/graph_21.gif" width="160" height="24"></td> |
36 |
<td width="45"><font color="#CC6633"><b>USA</b></font></td> |
37 |
</tr> |
38 |
<tr> |
39 |
<td width="175"><img src="fc/graph_22.gif" width="102" height="24"></td> |
40 |
<td width="45"><font color="#CC6633"><b>EU</b></font></td> |
41 |
</tr> |
42 |
<tr> |
43 |
<td width="175"><img src="fc/graph_23.gif" width="36" height="24"></td> |
44 |
<td width="45"><font color="#CC6633"><b>Others </b></font></td> |
45 |
</tr> |
46 |
</table> |
47 |
</td> |
48 |
</tr> |
49 |
</table> |
50 |
<p> <b>Quality system</b> </p> |
51 |
<p>Our quality system is aimed at:<br></p> |
52 |
<table width="480" border="0" cellspacing="0" cellpadding="0" bordercolordark="0"> |
53 |
<tr> |
54 |
<td width="150"><img src="fc/QualitySystem.jpg" width="150" height="144"> </td> |
55 |
<td width="350" valign="middle"> |
56 |
<table width="300" border="0" cellspacing="0" cellpadding="0"> |
57 |
<tr> |
58 |
<td valign="top" width="35"><img src="fc/point_2.gif" width="35" height="12"></td> |
59 |
<td>defining what to do and specifying how to do it</td> |
60 |
</tr> |
61 |
<tr> |
62 |
<td valign="top"><img src="fc/point_2.gif" width="35" height="12"></td> |
63 |
<td>justifying these activities (optimizing/validating)</td> |
64 |
</tr> |
65 |
<tr> |
66 |
<td valign="top"><img src="fc/point_2.gif" width="35" height="11"></td> |
67 |
<td>training</td> |
68 |
</tr> |
69 |
<tr> |
70 |
<td valign="top"><img src="fc/point_2.gif" width="35" height="12"></td> |
71 |
<td>following SOPs </td> |
72 |
</tr> |
73 |
<tr> |
74 |
<td valign="top"><img src="fc/point_2.gif" width="35" height="12"></td> |
75 |
<td>documenting performance </td> |
76 |
</tr> |
77 |
<tr> |
78 |
<td valign="top"><img src="fc/point_2.gif" width="35" height="12"></td> |
79 |
<td>inspecting implementation </td> |
80 |
</tr> |
81 |
<tr> |
82 |
<td valign="top"><img src="fc/point_2.gif" width="35" height="12"></td> |
83 |
<td>tracing failures/corrective actions </td> |
84 |
</tr> |
85 |
</table> |
86 |
</td> |
87 |
</tr> |
88 |
</table> |
89 |
<p> <b>Regulatory compliance</b> </p> |
90 |
<p>We have a spotless regulatory compliance track record. <br> |
91 |
</p> |
92 |
<table width="480" border="0" cellspacing="0" cellpadding="0" bordercolordark="0"> |
93 |
<tr> |
94 |
<td width="150"><img src="fc/RegulatoryComplience.jpg" width="150" height="150" border="0"> |
95 |
</td> |
96 |
<td width="350" valign="middle"> |
97 |
<table width="300" border="0" cellspacing="0" cellpadding="0"> |
98 |
<tr> |
99 |
<td valign="top" width="35"><img src="fc/point_2.gif" width="35" height="12"></td> |
100 |
<td> DMFs have been submitted for 11 APIs in USA, Canada, Europe, New |
101 |
Zealand, Australia & South Africa</td> |
102 |
</tr> |
103 |
<tr> |
104 |
<td valign="top"><img src="fc/point_2.gif" width="35" height="12"></td> |
105 |
<td>Since 1965 28 US DMFs have been submitted to the FDA </td> |
106 |
</tr> |
107 |
<tr> |
108 |
<td valign="top"><img src="fc/point_2.gif" width="35" height="12"></td> |
109 |
<td>Since 1965 FDA inspections have been continuously performed </td> |
110 |
</tr> |
111 |
<tr> |
112 |
<td valign="top"><img src="fc/point_2.gif" width="35" height="12"></td> |
113 |
<td>In 1999 a 20th FDA inspection was successfully performed on five |
114 |
products</td> |
115 |
</tr> |
116 |
</table> |
117 |
</td> |
118 |
</tr> |
119 |
</table> |
120 |
<p><b>Environmental protection</b><br> |
121 |
</p> |
122 |
<table width="500" border="0" cellspacing="0" cellpadding="0"> |
123 |
<tr> |
124 |
<td width="157" valign="top"><img src="fc/slap02.jpg" width="150" height="272"></td> |
125 |
<td width="343"> |
126 |
<p>Environmental protection is a key strategic priority for us. Ecological |
127 |
programs are managed in parallel with each of our new projects. </p> |
128 |
<p>PLIVA - Fine Chemicals has developed a programme designed to ensure that |
129 |
health and safety procedures and environmental protection safeguards comply |
130 |
with relevant enviromental laws and regulations and, in certain areas, |
131 |
with the requirements of various foreign regulatory bodies to which PLIVA's |
132 |
plants are subject. </p> |
133 |
<p>PLIVA's programme envisages rising production standards in the Republic |
134 |
of Croatia as the country orients itself increasingly towards EU standards |
135 |
in this area. </p> |
136 |
</td> |
137 |
</tr> |
138 |
</table> |